Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial.

The increased mortality in the vitamin C group in the LOVIT trial is not explained by ongoing vitamin C administration, but by the abrupt termination of vitamin C. The LOVIT trial findings should not be interpreted as evidence against vitamin C therapy for critically ill patients.